Abstract
The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Current Respiratory Medicine Reviews
Title:The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice
Volume: 8 Issue: 5
Author(s): Jose M. Porcel
Affiliation:
Keywords: Empyema, malignant pleural effusion, pleural effusion, tuberculous pleuritis, tumor markers.
Abstract: The analysis of pleural fluid (PF) is the most important diagnostic element in identifying the cause of pleural effusions. The measurement of proteins and lactate dehydrogenase in PF and blood establishes the transudative or exudative nature of effusions. Elevated concentrations of natriuretic peptide NT-proBNP (>1500 pg/mL) are virtually pathognomonic of heart failure. In exudates with predominantly polymorphonuclear leukocytes (>50%), a bacterial infection of the pleural space should be considered, particularly if pleural fluid C-reactive protein levels are high. A pleural pH <7.20 in a parapneumonic effusion is an indication for the need of a drainage tube. When lymphocytes predominate in an exudate, cancer and tuberculosis are the two main diagnoses to consider; an adenosine deaminase activity >35 U/L strongly supports the diagnosis of tuberculosis. The cytological study of PF is negative in 40% of malignant effusions. Performing immunocytochemistry on the cell block and measuring tumor markers, such as mesothelin, can increase the diagnostic yield for malignancy.
Export Options
About this article
Cite this article as:
Porcel M. Jose, The Diagnostic Utility of Pleural Fluid Tests in Clinical Practice, Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832485
DOI https://dx.doi.org/10.2174/157339812803832485 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heme Oxygenase -1 Gene Therapy: Recent Advances and Therapeutic Applications
Current Gene Therapy Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Inhibition of the Calcineurin-NFAT Signalling Cascade in the Treatment of Heart Failure
Recent Patents on Cardiovascular Drug Discovery Optimising the Use of Non-Invasive Ventilation in the Intensive Care Setting
Current Respiratory Medicine Reviews Contemporary Risk Assessment and Cardiovascular Outcomes in Peripheral Arterial Disease
Cardiovascular & Hematological Disorders-Drug Targets Immunologic Impact of Nutrient Depletion in Chronic Obstructive Pulmonary Disease
Current Drug Targets Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
Current Cardiology Reviews Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats
CNS & Neurological Disorders - Drug Targets The Versatile Stress Protein Mortalin as a Chaperone Therapeutic Agent
Protein & Peptide Letters Anthocyanins as a Potential Therapy for Diabetic Retinopathy
Current Medicinal Chemistry CDK-associated Cullin 1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Human Glioblastoma
Current Cancer Drug Targets Bioactive Peptides - Are There More Antihypertensive Mechanisms Beyond ACE Inhibition?
Current Pharmaceutical Design Relaxin and the Cardiovascular System: from Basic Science to Clinical Practice
Current Molecular Medicine Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
Current Pharmaceutical Design Recently Patented and Widely Used Valves for Transcatheter Aortic Valve Implantation
Recent Patents on Cardiovascular Drug Discovery Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery New Advances in Atrial Fibrillation Management: The Role of Apixaban
Current Drug Targets The Therapeutic Potential of RNA Interference: Novel Approaches for Cancer Treatment
Current Pharmaceutical Biotechnology Patent Annotations
Recent Patents on Biotechnology Mitophagy: A Novel Therapeutic Target for Treating DN
Current Medicinal Chemistry